-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Depreciation history and growth rate from Q1 2019 to Q3 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the quarter ending September 30, 2024 was $58.5K, a 2.84% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the twelve months ending September 30, 2024 was $224K, a 26.9% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2024 was $224K, a 26.9% increase from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2023 was $177K, a 83.7% increase from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2022 was $96.3K, a 64.8% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)